#India COVID-19 vaccination | Explore Tumblr Posts and Blogs

reasonsforhope · 1 year

Text

India was able to save more than 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, according to a Stanford University report.

The campaign also yielded a positive economic impact by preventing a loss of $18.3 billion, the working paper by Stanford University and Institute for Competitiveness titled 'Healing the Economy: Estimating the Economic Impact on India's Vaccination and Related Issues' released by Union health minister Mansukh Mandaviya on Friday suggested.

According to the Stanford report, the direct and total impact of vaccination varied from about $ 1.03 billion to $ 2.58 billion if minimum wages are considered within the age distribution category.

“The same, however, varied from about $3.49 billion to $ 8.7 billion if GDP per person employed (constant) is considered. The cumulative lifetime earnings of the lives saved through vaccination (in the working age group) rolled up to $ 21.5 billion. Moreover, since vaccination also saved the lives of the elderly, this indirectly helped prevent the health infrastructure from getting overwhelmed and thereby allowing for a more judicious use of the existing health infrastructure,” the report suggested.

Mandaviya said much before Covid-19 was declared a public health emergency by the World Health Organisation (WHO) in January 2020, processes and structures to focus dedicatedly on various facets of the pandemic management were put in place...

The Stanford working paper refers to a Lancet modelling study which estimated that in India around 3.4 million deaths were prevented by vaccination in the year 2021, an estimate based on officially reported deaths in India.

The paper also highlighted the impact of the lockdown and referred to the health ministry’s statistical analysis that the Covid-19 tally could have reached about two lakh (0.2 million) without lockdown by April 11, 2020.

Due to lockdown measures, the actual cases only went up to about 7,500 by April 11, 2020, making a case for the lockdown stronger."

-via Times of India, 2/25/23

#india #covid #covid 19 #vaccination #pandemic #covid relief #science and technology #public health #lockdown #good news #hope

42 notes · View notes

trendingnews2023 · 1 year

Text

#covid19 #covid 19 #covid 19 vaccine #covid 19 india #india covid19 #india #covidー19 #coronavirus

22 notes · View notes

allthebrazilianpolitics · 2 years

Text

Indian lab files for clearance in Brazil of covid-19 vax

Brazil's National Health Surveillance Agency (Anvisa) has announced it had received this week the request for registration of a COVID-19 vaccine that uses recombinant protein technology.

The application has been submitted by Zalika Farmacêutica Ltda., the local representatives in Brazil of India's Serum Institute, the developers of the Covovax drug, which is intended for people over 18 years of age.

”The protocol was received on Wednesday (April 27) and is already being evaluated by the technical areas involved. The deadline for the Agency's analysis is 60 days,” Anvisa said Friday in a statement.

According to Oswaldo Cruz Foundation (FioCruz) sources quoted by Agencia Brasil, recombinant vaccines use the technology of a non-replicating viral vector of chimpanzee adenovirus. The genome is genetically manipulated so that it can no longer replicate and then they insert the SARS-CoV-2 spike protein gene. Once obtained, the adenoviruses are amplified in large numbers using modified cells to allow amplification of the adenovirus and production of the vaccine in disposable bioreactors. These adenoviruses are purified, concentrated, and stabilized to make up the final vaccine. The vaccine goes through rigorous quality control before being sent to health clinics.

#brazil #brazilian politics #politics #coronavirus #covid 19 #india #fiocruz #vaccination #mod nise da silveira #image description in alt

7 notes · View notes

ummnews · 2 years

Text

USA: FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

www.UMMnews.org WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that…

View On WordPress

2 notes · View notes

pressnewsagencyllc · 15 days

Text

COVID-19 in India | What is the current scenario and how are we tackling it?

Story so far: During this poll season, mentions of the COVID-19 pandemic are still doing the rounds. Countering the Modi government’s claims of providing free novel Coronavirus-19 (COVID-19) vaccines to citizens, Congress general secretary Jairam Ramesh said the BJP was dragged into the act by the Opposition and the Supreme Court. He added that it was hard to forget the “extent of the…

View On WordPress

#Coronavirus #covid in india #COVID-19 #India #lockdown #long covid #Oxygen #vaccination #who.

0 notes

innonurse · 4 months

Text

A new web app for the COVID-19 immune antibody helps in vaccine scheduling

- By InnoNurse Staff -

With SARS-COV-2 infection rates on the rise once more, you might be wondering if you should receive a COVID-19 vaccination booster shot. Yale physicians have created a tool to assist in answering these questions.

Read more at Yale University

///

Other recent news and insights

Chefaa receives a $5.25 million budget boost to expand health-tech services throughout Saudi Arabia (Tech in Africa)

India: Peptris, an AI-powered drug discovery startup, has raised $1 million in pre-seed funding (The Financial Express)

#covid19 #covid 19 #pandemic #data science #medtech #vaccination #health tech #digital health #public health #ai #drug discovery #chefaa #saudi arabia #egypt #mena #india #peptris #pharma

0 notes

shaktiknowledgeblog · 1 year

Text

WHO said this big thing about booster dose, know what is the opinion of the expert? Booster Dose: Corona cases are continuously increasing in the country. In such a situation, there is a continuous debate about booster doses. In such a situation, do you know from experts whether you can take a booster dose again and again? Image Source: WHO who_booster_dose Corona cases are continuously…

View On WordPress

#booster dose #booster dose in india #Corona cases #coronavirus covid 19 india #covid 19 #Covid 19 Vaccine #healthy #who

0 notes

indizombie · 2 years

Quote

In July, free booster doses - or precaution doses as the government calls it - were provided to all adults for 75 days to mark 75 years of India's independence. But so far, India has administered just 298 million booster doses, according to the health ministry. "The booster vaccines have no demand as people now seem fed up with Covid," Mr Poonawala told reporters. "Honestly, I'm also fed up. We all are. Going forward, when people take a flu shot every year, they may take a Covid vaccine along with it. But in India, there is no culture of taking a flu shot every year, like in the West.”

‘India vaccine maker destroys 100 million doses of expired Covid jab’, BBC

#BBC #India #Covid-19 #booster vaccines #Adar Poonawalla #SII #flu shot

1 note · View note

krazyshoppy · 2 years

Text

कोरोना मामलों में राहत! बीते 24 घंटे में आए 5 हजार से कम नए मामले, 18 की गई जान

Corona virus in India: भारत में कोरोना (Corona) के मामलों में अब गिरावट दर्ज की जा रही है. इसी क्रम में भारत में पिछले 24 घंटों में कोरोना वायरस के 4 हजार 858 नए मामले दर्ज हुए. देश में संक्रमितों की कुल संख्या 4 करोड़ 45 लाख 39 हजार हो गई, जबकि ठीक होने वाले मरीजों की संख्या बढ़कर 4 करोड़ 39 लाख 62 हजार हो गई है. वही दूसरी ओर कोरोना के टीके लगवाने की संख्या में 13 लाख 59 हजार 361 का इजाफा हुआ…

View On WordPress

#corona virus #COVID-19 #Death #India #Vaccine #कोरोना वायरस #कोविड-19 #भारत #मौत #वैक्सीन।

0 notes

breaking-news-portal · 2 years

Text

Corona cases in the country cross 21 thousand again, the number of active cases is close to the figure of 1.5 lakh

Covid-19 Update in India: The increasing cases of corona across the world have raised concern once again. In India too, the number of patients infected with carona is increasing rapidly. Once again more than 21 thousand cases have been reported from Corona in the country. In the last 24 hours, 21,880 new cases of carona were reported. At the same time, 60 people lost their lives. The number of…

View On WordPress

0 notes

rudrjobdesk · 2 years

Text

तेज रफ़्तार से बढ़ रहा है कोरोना, 24 घंटों में आए इतने हजार मामले

Image Source : INDIA TV Corona Update Highlights पिछले 24 घंटों 4.32% की दर से हुई है कोरोना केसों में बढ़ोत्तरी पिछले 24 घंटों में 13 संक्रमितों ने अपनी जान भी गंवाई है पिछले 24 घंटों में 13,029 लोग कोविड के संक्रमण से उबरे हैं Corona Update: कोरोना के मामले फिर से बढ़ने लगे हैं। देश में बढ़ते संक्रमण और तेज होती रफ्तार अब डराने लगी है। देश में पिछले 24 घंटे में कोरोना से संक्रमण के 17336 नए…

View On WordPress

0 notes

supernews · 2 years

Text

Covaxin booster dose enhances effectiveness against Delta, Omicron: ICMR

The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.

The protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy of the Covaxin against Omicron variants were studied in a Syrian hamster model (animal model to study human-associated diseases), it said.

The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed, it added.

The findings of the study have been published on Tuesday on bioRxiv, a pre-print server and have not been peer reviewed.

"In the Delta infection study, where we compared the protective response between the two and three-dose regimens, we could observe the advantage of the booster dose vaccination in the protection. Although the neutralising antibody levels were comparable among the groups, lung disease severity was found more reduced after the three dose vaccination.

"The virus shedding and viral organ load were considerably reduced in both the two dose and three-dose immunised animals indicating the vaccine efficacy against Delta variant," the study by Indian Council of Medical Research and Bharat Biotech said.